Specific interaction of HIV-1 and HIV-2 surface envelope glycoproteins with monolayers of galactosylceramide and ganglioside GM3

被引:122
作者
Hammache, D
Piéroni, G
Yahi, N
Delézay, O
Koch, N
Lafont, H
Tamalet, C
Fantini, J [1 ]
机构
[1] Fac Sci & Tech St Jerome, Lab Biochim & Biol Nutr, CNRS, UPRESA 6033, F-13397 Marseille 20, France
[2] INSERM, U130, F-13009 Marseille, France
[3] Hop Enfants La Timone, UF SIDA, Virol Lab, F-13005 Marseille, France
关键词
D O I
10.1074/jbc.273.14.7967
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cellular glycosphingolipids mediate the fusion between some viruses and the plasma membrane of target cells, In the present study, we have analyzed the interaction of human immunodeficiency virus (HIV)-1 and HIV-2 surface envelope glycoproteins from distinct viral isolates with monolayers of various glycosphingolipids at the air-water interface, The penetration of the viral glycoproteins into glycosphingolipid monolayers was detected as an increase in the surface pressure, We found that HIV-1 recombinant gp120 (IIIB isolate) could penetrate into a monomolecular film of alpha-hydroxylated galactosylceramide (GalCer-HFA), while ceramides, GluCer, and nonhydroxylated GalCer were totally inactive, The glycoproteins isolated from HIV-1 isolates LAI and NDK and from HIV-2(ROD) could also interact with a GalCer-HFA monolayer, whereas gp120 from HIV-1(SEN) and HIV-1(89.6) did not react, These data correlated with the ability of the corresponding viruses to gain entry into the CD4(-)/GalCer(+) cell line HT-29, demonstrating the determinant role of GalCer-HFA in this CD4-independent pathway of HIV-1 and HIV-2 infection. In contrast, all HIV-1 and HIV-2 glycoproteins tested were found to interact with a monolayer of GM3, a ganglioside abundantly expressed in the plasma membrane of CD4(+) lymphocytes and macrophages. A V3 loop-derived synthetic peptide inhibitor of HIV-1 and HIV-2 infection in both CD4(-) and CD4(+) cells could penetrate into various glycosphingolipid monolayers, including GalCer-HFA and GM3, Taken together, these data suggest that the adsorption of human immunodeficiency viruses to the surface of target cells involves an interaction between the V3 domain of the surface envelope glycoprotein and specific glycosphingolipids, i.e. GalCer-HFA for CD4(-) cells and GM3 for CD4(+) cells.
引用
收藏
页码:7967 / 7971
页数:5
相关论文
共 45 条
[1]   ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS) [J].
BARRESINOUSSI, F ;
CHERMANN, JC ;
REY, F ;
NUGEYRE, MT ;
CHAMARET, S ;
GRUEST, J ;
DAUGUET, C ;
AXLERBLIN, C ;
VEZINETBRUN, F ;
ROUZIOUX, C ;
ROZENBAUM, W ;
MONTAGNIER, L .
SCIENCE, 1983, 220 (4599) :868-871
[2]   GALACTOSYL CERAMIDE OR A DERIVATIVE IS AN ESSENTIAL COMPONENT OF THE NEURAL RECEPTOR FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN GP120 [J].
BHAT, S ;
SPITALNIK, SL ;
GONZALEZSCARANO, F ;
SILBERBERG, DH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (16) :7131-7134
[3]   Human immunodeficiency virus type 1 tropism for T-lymphoid cell lines: Role of the V3 loop and C4 envelope determinants [J].
Carrillo, A ;
Ratner, L .
JOURNAL OF VIROLOGY, 1996, 70 (02) :1301-1309
[4]   AN INFECTIOUS MOLECULAR CLONE OF AN UNUSUAL MACROPHAGE-TROPIC AND HIGHLY CYTOPATHIC STRAIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
COLLMAN, R ;
BALLIET, JW ;
GREGORY, SA ;
FRIEDMAN, H ;
KOLSON, DL ;
NATHANSON, N ;
SRINIVASAN, A .
JOURNAL OF VIROLOGY, 1992, 66 (12) :7517-7521
[5]   BINDING OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-I (HIV-1) GP120 TO GALACTOSYLCERAMIDE (GALCER) - RELATIONSHIP TO THE V3 LOOP [J].
COOK, DG ;
FANTINI, J ;
SPITALNIK, SL ;
GONZALEZSCARANO, F .
VIROLOGY, 1994, 201 (02) :206-214
[6]   Co-expression of CXCR4/fusin and galactosylceramide in the human intestinal epithelial cell line HT-29 [J].
Delezay, O ;
Koch, N ;
Yahi, N ;
Hammache, D ;
Tourres, C ;
Tamalet, C ;
Fantini, J .
AIDS, 1997, 11 (11) :1311-1318
[7]   Detection of functional galactosylceramide (GalCer) receptors on CD4-negative HIV-1 target cells [J].
Delezay, O ;
Yahi, N ;
Fantini, J .
PERSPECTIVES IN DRUG DISCOVERY AND DESIGN, 1996, 5 :192-202
[8]   SPC3, a V3 loop-derived synthetic peptide inhibitor of HIV-1 infection, binds to cell surface glycosphingolipids [J].
Delezay, O ;
Hammache, D ;
Fantini, J ;
Yahi, N .
BIOCHEMISTRY, 1996, 35 (49) :15663-15671
[9]   A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors [J].
Doranz, BJ ;
Rucker, J ;
Yi, YJ ;
Smyth, RJ ;
Samson, M ;
Peiper, SC ;
Parmentier, M ;
Collman, RG ;
Doms, RW .
CELL, 1996, 85 (07) :1149-1158
[10]  
ELLRODT A, 1984, LANCET, V1, P1383